Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mycophenolate mofetil in juvenile dermatomyositis: a case series

Identifieur interne : 000262 ( France/Analysis ); précédent : 000261; suivant : 000263

Mycophenolate mofetil in juvenile dermatomyositis: a case series

Auteurs : Rawane Dagher [France] ; Marine Desjonquères [France] ; Agnès Duquesne [France] ; Pierre Quartier [France] ; Brigitte Bader-Meunier [France] ; Michel Fischbach [France] ; Vincent Guiguonis [France] ; Georges Picherot [France] ; Rolando Cimaz [France]

Source :

RBID : ISTEX:11AD0291EC75E0A5A03D770BDA6C30E194989036

English descriptors

Abstract

Abstract: The objective of this study was to report the use of Mycophenolate Mofetil (MMF) in Juvenile Dermatomyositis (JDM). A retrospective chart review of children diagnosed with JDM having received MMF was performed. Response was evaluated 3 months after the onset of MMF by comparing muscle strength and steroid dosage before and after treatment. A good response was defined by global improvement concerning weakness and fatigability as evaluated subjectively by the physician along with a gain of at least 4 points on each of 2 muscle testings (Manual Muscle Testing, MMT and Childhood Myositis Assessment Score, CMAS) and/or a decrease of >15% of the corticosteroid dosage. Eight patients were identified. Except for one, all had received MMF secondary to an initial therapy of conventional immunosuppressants. Six patients showed good response by our predefined criteria. Changes of muscle testing scores ranged between +0 to +21 points (mean = +10.6) for the MMT and between +3 and +11 (mean = +7) for the CMAS. Corticosteroid tapering varied from 0 to 50%, with a mean of 18%. In most cases, follow-up was available for many months (up to 26); overall, we observed only one complication: a transient neutropenia in a patient concurrently receiving another immunosuppressant. This small series is the first published report on the use of MMF in JDM and suggests it is safe. Prospective larger studies are required to further elucidate the use of MMF in JDM.

Url:
DOI: 10.1007/s00296-010-1653-5


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:11AD0291EC75E0A5A03D770BDA6C30E194989036

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mycophenolate mofetil in juvenile dermatomyositis: a case series</title>
<author>
<name sortKey="Dagher, Rawane" sort="Dagher, Rawane" uniqKey="Dagher R" first="Rawane" last="Dagher">Rawane Dagher</name>
</author>
<author>
<name sortKey="Desjonqueres, Marine" sort="Desjonqueres, Marine" uniqKey="Desjonqueres M" first="Marine" last="Desjonquères">Marine Desjonquères</name>
</author>
<author>
<name sortKey="Duquesne, Agnes" sort="Duquesne, Agnes" uniqKey="Duquesne A" first="Agnès" last="Duquesne">Agnès Duquesne</name>
</author>
<author>
<name sortKey="Quartier, Pierre" sort="Quartier, Pierre" uniqKey="Quartier P" first="Pierre" last="Quartier">Pierre Quartier</name>
</author>
<author>
<name sortKey="Bader Meunier, Brigitte" sort="Bader Meunier, Brigitte" uniqKey="Bader Meunier B" first="Brigitte" last="Bader-Meunier">Brigitte Bader-Meunier</name>
</author>
<author>
<name sortKey="Fischbach, Michel" sort="Fischbach, Michel" uniqKey="Fischbach M" first="Michel" last="Fischbach">Michel Fischbach</name>
</author>
<author>
<name sortKey="Guiguonis, Vincent" sort="Guiguonis, Vincent" uniqKey="Guiguonis V" first="Vincent" last="Guiguonis">Vincent Guiguonis</name>
</author>
<author>
<name sortKey="Picherot, Georges" sort="Picherot, Georges" uniqKey="Picherot G" first="Georges" last="Picherot">Georges Picherot</name>
</author>
<author>
<name sortKey="Cimaz, Rolando" sort="Cimaz, Rolando" uniqKey="Cimaz R" first="Rolando" last="Cimaz">Rolando Cimaz</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:11AD0291EC75E0A5A03D770BDA6C30E194989036</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1007/s00296-010-1653-5</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-P0ZVCL2D-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001F36</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001F36</idno>
<idno type="wicri:Area/Istex/Curation">001F36</idno>
<idno type="wicri:Area/Istex/Checkpoint">000635</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000635</idno>
<idno type="wicri:doubleKey">0172-8172:2010:Dagher R:mycophenolate:mofetil:in</idno>
<idno type="wicri:Area/Main/Merge">001693</idno>
<idno type="wicri:Area/Main/Curation">001690</idno>
<idno type="wicri:Area/Main/Exploration">001690</idno>
<idno type="wicri:Area/France/Extraction">000262</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Mycophenolate mofetil in juvenile dermatomyositis: a case series</title>
<author>
<name sortKey="Dagher, Rawane" sort="Dagher, Rawane" uniqKey="Dagher R" first="Rawane" last="Dagher">Rawane Dagher</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Lyon, Femme-Mère-Enfant Hospital, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Desjonqueres, Marine" sort="Desjonqueres, Marine" uniqKey="Desjonqueres M" first="Marine" last="Desjonquères">Marine Desjonquères</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Lyon, Femme-Mère-Enfant Hospital, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Duquesne, Agnes" sort="Duquesne, Agnes" uniqKey="Duquesne A" first="Agnès" last="Duquesne">Agnès Duquesne</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Lyon, Femme-Mère-Enfant Hospital, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Quartier, Pierre" sort="Quartier, Pierre" uniqKey="Quartier P" first="Pierre" last="Quartier">Pierre Quartier</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Lyon, Femme-Mère-Enfant Hospital, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bader Meunier, Brigitte" sort="Bader Meunier, Brigitte" uniqKey="Bader Meunier B" first="Brigitte" last="Bader-Meunier">Brigitte Bader-Meunier</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Lyon, Femme-Mère-Enfant Hospital, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fischbach, Michel" sort="Fischbach, Michel" uniqKey="Fischbach M" first="Michel" last="Fischbach">Michel Fischbach</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Lyon, Femme-Mère-Enfant Hospital, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Guiguonis, Vincent" sort="Guiguonis, Vincent" uniqKey="Guiguonis V" first="Vincent" last="Guiguonis">Vincent Guiguonis</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Lyon, Femme-Mère-Enfant Hospital, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Picherot, Georges" sort="Picherot, Georges" uniqKey="Picherot G" first="Georges" last="Picherot">Georges Picherot</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Lyon, Femme-Mère-Enfant Hospital, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cimaz, Rolando" sort="Cimaz, Rolando" uniqKey="Cimaz R" first="Rolando" last="Cimaz">Rolando Cimaz</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Lyon, Femme-Mère-Enfant Hospital, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Rheumatology International</title>
<title level="j" type="sub">Clinical and Experimental Investigations</title>
<title level="j" type="abbrev">Rheumatol Int</title>
<idno type="ISSN">0172-8172</idno>
<idno type="eISSN">1437-160X</idno>
<imprint>
<publisher>Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="2012-03-01">2012-03-01</date>
<biblScope unit="volume">32</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="711">711</biblScope>
<biblScope unit="page" to="716">716</biblScope>
</imprint>
<idno type="ISSN">0172-8172</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0172-8172</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Juvenile dermatomyositis</term>
<term>Mycophenolate mofetil</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The objective of this study was to report the use of Mycophenolate Mofetil (MMF) in Juvenile Dermatomyositis (JDM). A retrospective chart review of children diagnosed with JDM having received MMF was performed. Response was evaluated 3 months after the onset of MMF by comparing muscle strength and steroid dosage before and after treatment. A good response was defined by global improvement concerning weakness and fatigability as evaluated subjectively by the physician along with a gain of at least 4 points on each of 2 muscle testings (Manual Muscle Testing, MMT and Childhood Myositis Assessment Score, CMAS) and/or a decrease of >15% of the corticosteroid dosage. Eight patients were identified. Except for one, all had received MMF secondary to an initial therapy of conventional immunosuppressants. Six patients showed good response by our predefined criteria. Changes of muscle testing scores ranged between +0 to +21 points (mean = +10.6) for the MMT and between +3 and +11 (mean = +7) for the CMAS. Corticosteroid tapering varied from 0 to 50%, with a mean of 18%. In most cases, follow-up was available for many months (up to 26); overall, we observed only one complication: a transient neutropenia in a patient concurrently receiving another immunosuppressant. This small series is the first published report on the use of MMF in JDM and suggests it is safe. Prospective larger studies are required to further elucidate the use of MMF in JDM.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement>
<li>Lyon</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Auvergne-Rhône-Alpes">
<name sortKey="Dagher, Rawane" sort="Dagher, Rawane" uniqKey="Dagher R" first="Rawane" last="Dagher">Rawane Dagher</name>
</region>
<name sortKey="Bader Meunier, Brigitte" sort="Bader Meunier, Brigitte" uniqKey="Bader Meunier B" first="Brigitte" last="Bader-Meunier">Brigitte Bader-Meunier</name>
<name sortKey="Cimaz, Rolando" sort="Cimaz, Rolando" uniqKey="Cimaz R" first="Rolando" last="Cimaz">Rolando Cimaz</name>
<name sortKey="Desjonqueres, Marine" sort="Desjonqueres, Marine" uniqKey="Desjonqueres M" first="Marine" last="Desjonquères">Marine Desjonquères</name>
<name sortKey="Duquesne, Agnes" sort="Duquesne, Agnes" uniqKey="Duquesne A" first="Agnès" last="Duquesne">Agnès Duquesne</name>
<name sortKey="Fischbach, Michel" sort="Fischbach, Michel" uniqKey="Fischbach M" first="Michel" last="Fischbach">Michel Fischbach</name>
<name sortKey="Guiguonis, Vincent" sort="Guiguonis, Vincent" uniqKey="Guiguonis V" first="Vincent" last="Guiguonis">Vincent Guiguonis</name>
<name sortKey="Picherot, Georges" sort="Picherot, Georges" uniqKey="Picherot G" first="Georges" last="Picherot">Georges Picherot</name>
<name sortKey="Quartier, Pierre" sort="Quartier, Pierre" uniqKey="Quartier P" first="Pierre" last="Quartier">Pierre Quartier</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000262 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000262 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:11AD0291EC75E0A5A03D770BDA6C30E194989036
   |texte=   Mycophenolate mofetil in juvenile dermatomyositis: a case series
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021